Preclinical Safety Evaluation of AAV2-sFLT01— A Gene Therapy for Age-related Macular Degeneration

Title
Preclinical Safety Evaluation of AAV2-sFLT01— A Gene Therapy for Age-related Macular Degeneration
Authors
Keywords
-
Journal
MOLECULAR THERAPY
Volume 19, Issue 2, Pages 326-334
Publisher
Elsevier BV
Online
2010-11-30
DOI
10.1038/mt.2010.258

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search